:max_bytes(150000):strip_icc()/long-term-effects-of-antidepressants-4158064_V2-01-64cad678074d4e45b0b85840567c27ef.png "long-term-effects-of-antidepressants-4158064_V2-01-64cad678074d4e45b0b85840567c27ef.png")
Approximately 7 million people in France use antidepressants, a population that includes seniors facing heightened risks of stroke and cognitive decline, according to reports from Medisite.fr and La République des Pyrénées. Researchers are now questioning whether the current patterns of antidepressant prescription require a systemic rethink, particularly for patients over 65.
Why are antidepressants a concern for seniors?
While antidepressants are widely prescribed, their safety profile changes as patients age. According to Medisite.fr, these medications are associated with an increased risk of stroke in individuals over the age of 65. This specific demographic vulnerability has led to calls for a broader evaluation of how these drugs are utilized in elderly populations.
Beyond cardiovascular risks, the impact on brain function is a primary concern. La République des Pyrénées reports that the medications taken by these 7 million users may also trigger cognitive impairments, complicating the health management of older adults who may already be experiencing age-related decline.
How are relapse symptoms being misidentified?
A critical issue in geriatric care is the potential for misdiagnosis during antidepressant treatment. According to SeniorActu, clinical trials have frequently identified certain symptoms in patients over 65 as a “relapse” of depression. However, the report indicates that these symptoms may not actually be a return of the depressive disorder, suggesting a gap in how clinicians interpret the recovery and stability of senior patients.
What is the link between antihistamines and dementia?
Cognitive risks are not limited to antidepressants. Atlantico reports that the prolonged use of certain antihistamines, commonly used to treat hay fever, is linked to an increased risk of developing dementia. This suggests a broader pattern where long-term reliance on specific medication classes may negatively impact neurological health in aging populations.
Comparing medication risks in the elderly
The data from these reports highlights two different pathways to cognitive decline based on the medication used:
- Antidepressants: Associated with general cognitive impairment and a specific increase in stroke risk for those 65 and older, according to Medisite.fr and La République des Pyrénées.
- Antihistamines: Linked specifically to an elevated risk of dementia when used over a prolonged period, according to Atlantico.
These findings suggest that for the millions of French citizens on these regimens, the benefit of the medication must be weighed against the potential for long-term neurological and vascular damage.
